Sucampo Announces Japanese Government Funding for Unoprostone Isopropyl Development in Retinitis Pigmentosa

[Business Wire] – BETHESDA, Md.–(BUSINESSWIRE)– Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) today announced that the Japan Science and Technology Agency (JST) has adopted unoprostone isopropyl ophthalmic solution .15% … more

View todays social media effects on SCMP

View the latest stocks trending across Twitter. Click to view dashboard

See who Sucampo is hiring next, click here to view